Article

Drs. Kaufman, Watson named journal editors-in-chief

Rockville, MD-The Association for Research in Vision and Ophthalmology (ARVO) selected Paul L. Kaufman, MD, as editor-in-chief of Investigative Ophthalmology & Visual Science, and Andrew B. Watson, PhD, as editor-in-chief of Journal of Vision.

Rockville, MD-The Association for Research in Vision and Ophthalmology (ARVO) selected Paul L. Kaufman, MD, as editor-in-chief of Investigative Ophthalmology & Visual Science, and Andrew B. Watson, PhD, as editor-in-chief of Journal of Vision.

Dr. Kaufman will serve a 5-year term beginning in January 2008. Dr. Kaufman, the Peter A. Duehr professor and chairman, department of ophthalmology and visual sciences, University of Wisconsin-Madison, will replace Robert N. Frank, MD. Dr. Kaufman currently is executive vice president of ARVO and serves as a member of the Glaucoma Foundation's Board of Directors and the Board of Governors of the ARVO Foundation for Eye Research.

Dr. Watson has served as editor-in-chief of the Journal of Vision since its inception in 2000, and this selection will confirm his position through 2013. Dr. Watson, senior scientist for vision research and director of the Vision Group at NASA Ames Research Center, Moffett Field, CA, is the recipient of the 1990 H. Julian Allen Award and has served as a member of the National Research Council Committee on Vision.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times) ASCRS 2025: Mark Lobanoff, MD, on making the move to office-based surgery
Barsha Lal, PhD, discusses the way low dose atropine affects accommodative amplitude and dynamics at the 2025 ARVO meeting
(Image credit: Ophthalmology Times) NeuroOp Guru: When eye findings should prompt neuroimaging in suspected neuro-Behcet disease
At the Association for Research in Vision and Ophthalmology (ARVO) meeting, Katherine Talcott, MD, a retina specialist at Cleveland Clinic, shared her findings on EYP-1901 (EyePoint Pharmaceuticals) in the phase 2 DAVIO study.
Dr. Jogin Desai, founder of Eyestem Research, discusses his research at the Association for Research in Vision and Ophthalmology.
(Image credit: Ophthalmology Times) ASCRS 2025: Michael Rivers, MD, shares his takeaways as a panelist at the inaugural SightLine event
(Image credit: Ophthalmology Times) ASCRS 2025: Karl Stonecipher, MD, on LASIK outcomes using an aspheric excimer laser for high myopia
John Tan talks about an emergency triage framework for retinal artery occlusion at the 2025 Association for Research in Vision and Ophthalmology (ARVO) meeting.
Dr Robert Maloney at the 2025 Controversies in Modern Eye Care meeting
Wendy Lee, MD, MS, at Controversies in Modern Eye Care 2025.
© 2025 MJH Life Sciences

All rights reserved.